Authors:
Scardino, A
Alves, P
Gross, DA
Tourdot, S
Graff-Dubois, S
Angevin, E
Firat, H
Chouaib, S
Lemonier, F
Nadler, LM
Cardoso, AA
Kosmatopoulos, K
Citation: A. Scardino et al., Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, EUR J IMMUN, 31(11), 2001, pp. 3261-3270
Authors:
Firat, H
Tourdot, S
Ureta-Vidal, A
Scardino, A
Suhrbier, A
Buseyne, F
Riviere, Y
Danos, O
Michel, ML
Kosmatopoulos, K
Lemonnier, FA
Citation: H. Firat et al., Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice, EUR J IMMUN, 31(10), 2001, pp. 3064-3074
Authors:
Chouaib, S
Echchakir, H
Angevin, E
Guerra, N
Kosmatopoulos, K
Caignard, A
Lim, A
Baron, V
Ferradini, L
Mami-Chouaib, F
Citation: S. Chouaib et al., Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring, B CANCER, 88(8), 2001, pp. 733-740
Authors:
Tourdot, S
Scardino, A
Saloustrou, E
Gross, DA
Pascolo, S
Cordopatis, P
Lemonnier, FA
Kosmatopoulos, K
Citation: S. Tourdot et al., A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes, EUR J IMMUN, 30(12), 2000, pp. 3411-3421
Authors:
Firat, H
Garcia-Pons, F
Tourdot, S
Pascolo, S
Scardino, A
Garcia, Z
Michel, ML
Jack, RW
Jung, G
Kosmatopoulos, K
Mateo, L
Suhrbier, A
Lemonnier, FA
Langlade-Demoyen, P
Citation: H. Firat et al., H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies, EUR J IMMUN, 29(10), 1999, pp. 3112-3121